Daesung Microbiological Labs. Co. Ltd (036480) - Total Liabilities
Based on the latest financial reports, Daesung Microbiological Labs. Co. Ltd (036480) has total liabilities worth ₩22.56 Billion KRW (≈ $15.29 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Daesung Microbiological Labs. Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Daesung Microbiological Labs. Co. Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Daesung Microbiological Labs. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Daesung Microbiological Labs. Co. Ltd asset portfolio.
Daesung Microbiological Labs. Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Daesung Microbiological Labs. Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SYZYGY AG
XETRA:SYZ
|
Germany | €30.20 Million |
|
PRI EKOPARK SA ZY -10
F:NPA
|
Germany | €18.98 Million |
|
Indian Terrain Fashions Limited
NSE:INDTERRAIN
|
India | Rs2.55 Billion |
|
Orbital Corporation Ltd
AU:OEC
|
Australia | AU$8.85 Million |
|
Good Times Restaurants Inc
NASDAQ:GTIM
|
USA | $44.05 Million |
|
Organic Tea Cosmetics Holdings Company Limited
KQ:900300
|
Korea | ₩82.74 Billion |
|
Alma Metals Ltd
AU:ALM
|
Australia | AU$560.22K |
|
Hanchang
KO:005110
|
Korea | ₩85.91 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Daesung Microbiological Labs. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Daesung Microbiological Labs. Co. Ltd to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Daesung Microbiological Labs. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Daesung Microbiological Labs. Co. Ltd (2012–2025)
The table below shows the annual total liabilities of Daesung Microbiological Labs. Co. Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩22.56 Billion ≈ $15.29 Million |
-2.89% |
| 2024-12-31 | ₩23.23 Billion ≈ $15.74 Million |
-13.78% |
| 2023-12-31 | ₩26.94 Billion ≈ $18.26 Million |
+2.55% |
| 2022-12-31 | ₩26.27 Billion ≈ $17.80 Million |
+2.56% |
| 2021-12-31 | ₩25.62 Billion ≈ $17.36 Million |
-1.29% |
| 2020-12-31 | ₩25.95 Billion ≈ $17.59 Million |
+65.55% |
| 2019-12-31 | ₩15.68 Billion ≈ $10.62 Million |
+208.03% |
| 2018-12-31 | ₩5.09 Billion ≈ $3.45 Million |
+13.45% |
| 2017-12-31 | ₩4.49 Billion ≈ $3.04 Million |
-31.99% |
| 2016-12-31 | ₩6.60 Billion ≈ $4.47 Million |
-9.96% |
| 2015-12-31 | ₩7.33 Billion ≈ $4.96 Million |
+10.10% |
| 2014-12-31 | ₩6.65 Billion ≈ $4.51 Million |
-27.91% |
| 2013-12-31 | ₩9.23 Billion ≈ $6.25 Million |
+60.20% |
| 2012-12-31 | ₩5.76 Billion ≈ $3.90 Million |
-- |
About Daesung Microbiological Labs. Co. Ltd
Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in U… Read more